Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D) in adults

A Kemppinen; C Howell; V Allgar; M Dodd; J Gregson; C Knowles; J McLaughlin; P Pandya; P Whorwell; E Markaryan; Y Yiannakou

doi:10.21203/rs.2.12205/v1

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D) in adults

A Kemppinen
, C Howell
, V Allgar
, M Dodd
, J Gregson
, C Knowles
, J McLaughlin
, P Pandya
, P Whorwell
, E Markaryan
, Y Yiannakou

Peninsula Medical School

Research output: Working paper / Preprint › Preprint

Original language	English
Number of pages	0
DOIs	https://doi.org/10.21203/rs.2.12205/v1
Publication status	Published - 31 Jul 2019

Access to Document

10.21203/rs.2.12205/v1

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults
Kemppinen, A., Howell, C., Allgar, V., Dodd, M., Gregson, J., Knowles, C., McLaughlin, J., Pandya, P., Whorwell, P., Markaryan, E. & Yiannakou, Y., Dec 2020, In: Trials. 21, 1
Research output: Contribution to journal › Article › peer-review

Cite this

Kemppinen, A., Howell, C., Allgar, V., Dodd, M., Gregson, J., Knowles, C., McLaughlin, J., Pandya, P., Whorwell, P., Markaryan, E., & Yiannakou, Y. (2019). Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D) in adults. https://doi.org/10.21203/rs.2.12205/v1

@techreport{4f7439d4461b4e87b29a01854cb14b97,

title = "Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel{\textregistered} in the treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D) in adults",

author = "A Kemppinen and C Howell and V Allgar and M Dodd and J Gregson and C Knowles and J McLaughlin and P Pandya and P Whorwell and E Markaryan and Y Yiannakou",

year = "2019",

month = jul,

day = "31",

doi = "10.21203/rs.2.12205/v1",

language = "English",

type = "WorkingPaper",

}

Kemppinen, A, Howell, C, Allgar, V, Dodd, M, Gregson, J, Knowles, C, McLaughlin, J, Pandya, P, Whorwell, P, Markaryan, E & Yiannakou, Y 2019 'Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D) in adults'. https://doi.org/10.21203/rs.2.12205/v1

TY - UNPB

T1 - Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D) in adults

AU - Kemppinen, A

AU - Howell, C

AU - Allgar, V

AU - Dodd, M

AU - Gregson, J

AU - Knowles, C

AU - McLaughlin, J

AU - Pandya, P

AU - Whorwell, P

AU - Markaryan, E

AU - Yiannakou, Y

PY - 2019/7/31

Y1 - 2019/7/31

U2 - 10.21203/rs.2.12205/v1

DO - 10.21203/rs.2.12205/v1

M3 - Preprint

BT - Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D) in adults

ER -

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D) in adults

Access to Document

Research output

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults

Cite this